Suppr超能文献

激动剂结合核受体的共抑制因子。

Corepressors of agonist-bound nuclear receptors.

作者信息

Gurevich Igor, Flores Anthony M, Aneskievich Brian J

机构信息

Graduate Program in Pharmacology/Toxicology, Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT 06269, USA.

出版信息

Toxicol Appl Pharmacol. 2007 Sep 15;223(3):288-98. doi: 10.1016/j.taap.2007.05.019. Epub 2007 Jun 14.

Abstract

Nuclear receptors (NRs) rely on coregulator proteins to modulate transcription of target genes. NR coregulators can be broadly subdivided into coactivators which potentiate transcription and corepressors which silence gene expression. The prevailing view of coregulator action holds that in the absence of agonist the receptor interacts with a corepressor via the corepressor nuclear receptor (CoRNR, "corner") box motifs within the corepressor. Upon agonist binding, a conformational change in the receptor causes the shedding of corepressor and the binding of a coactivator which interacts with the receptor via NR boxes within the coregulator. This view was challenged with the discovery of RIP140 which acts as a NR corepressor in the presence of agonist and utilizes NR boxes. Since then a number of other corepressors of agonist-bound NRs have been discovered. Among them are LCoR, PRAME, REA, MTA1, NSD1, and COPR1 Although they exhibit a great diversity of structure, mechanism of repression and pathophysiological function, these corepressors frequently have one or more NR boxes and often recruit histone deacetylases to exert their repressive effects. This review highlights these more recently discovered corepressors and addresses their potential functions in transcription regulation, disease pharmacologic responses and xenobiotic metabolism.

摘要

核受体(NRs)依靠共调节蛋白来调节靶基因的转录。NR共调节蛋白可大致分为增强转录的共激活因子和使基因表达沉默的共抑制因子。关于共调节蛋白作用的主流观点认为,在没有激动剂的情况下,受体通过共抑制因子内的共抑制因子核受体(CoRNR,“转角”)框基序与共抑制因子相互作用。激动剂结合后,受体内的构象变化导致共抑制因子脱落,以及与共调节蛋白内NR框相互作用的共激活因子的结合。RIP140的发现对这一观点提出了挑战,RIP140在激动剂存在的情况下作为NR共抑制因子起作用,并利用NR框。从那时起,又发现了许多其他与激动剂结合的NR共抑制因子。其中包括LCoR、PRAME、REA、MTA1、NSD1和COPR1。尽管它们在结构、抑制机制和病理生理功能上表现出很大的多样性,但这些共抑制因子通常有一个或多个NR框,并且经常招募组蛋白脱乙酰酶来发挥其抑制作用。这篇综述重点介绍了这些最近发现的共抑制因子,并探讨了它们在转录调控、疾病药理反应和外源性物质代谢中的潜在功能。

相似文献

1
Corepressors of agonist-bound nuclear receptors.
Toxicol Appl Pharmacol. 2007 Sep 15;223(3):288-98. doi: 10.1016/j.taap.2007.05.019. Epub 2007 Jun 14.
2
Corepressor recruitment by agonist-bound nuclear receptors.
Vitam Horm. 2004;68:123-43. doi: 10.1016/S0083-6729(04)68004-6.
3
Nuclear receptor repression: regulatory mechanisms and physiological implications.
Prog Mol Biol Transl Sci. 2009;87:235-59. doi: 10.1016/S1877-1173(09)87007-5. Epub 2009 Oct 7.
5
Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
Mol Endocrinol. 2004 Jun;18(6):1376-95. doi: 10.1210/me.2003-0421. Epub 2004 Mar 11.
6
Molecular dynamics simulations for human CAR inverse agonists.
J Chem Inf Model. 2012 Feb 27;52(2):457-64. doi: 10.1021/ci200432k. Epub 2012 Jan 25.
7
MTA family of coregulators in nuclear receptor biology and pathology.
Nucl Recept Signal. 2007 Nov 30;5:e010. doi: 10.1621/nrs.05010.
8
Androgen receptor corepressors: an overview.
Prostate. 2005 May 1;63(2):117-30. doi: 10.1002/pros.20170.

引用本文的文献

1
Epigenetic regulation of nuclear receptors: Implications for endocrine-related diseases and therapeutic strategies.
Genes Dis. 2024 Dec 4;12(4):101481. doi: 10.1016/j.gendis.2024.101481. eCollection 2025 Jul.
2
Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries.
Physiol Rev. 2024 Jan 1;104(1):473-532. doi: 10.1152/physrev.00021.2023. Epub 2023 Sep 21.
3
In the quest for histone deacetylase inhibitors: current trends in the application of multilayered computational methods.
Amino Acids. 2023 Dec;55(12):1709-1726. doi: 10.1007/s00726-023-03297-y. Epub 2023 Jun 27.
4
The PPAR Pocket: Renewed Opportunities for Drug Development.
PPAR Res. 2020 Jul 1;2020:9657380. doi: 10.1155/2020/9657380. eCollection 2020.
5
Estradiol-Induced Epigenetically Mediated Mechanisms and Regulation of Gene Expression.
Int J Mol Sci. 2020 Apr 30;21(9):3177. doi: 10.3390/ijms21093177.
7
RaRF confers RA resistance by sequestering RAR to the nucleolus and regulating MCL1 in leukemia cells.
Oncogene. 2018 Jan 18;37(3):352-362. doi: 10.1038/onc.2017.329. Epub 2017 Sep 25.
8
RIPK1 binds to vitamin D receptor and decreases vitamin D-induced growth suppression.
J Steroid Biochem Mol Biol. 2017 Oct;173:157-167. doi: 10.1016/j.jsbmb.2017.01.024. Epub 2017 Feb 1.
9
A New Role for ERα: Silencing via DNA Methylation of Basal, Stem Cell, and EMT Genes.
Mol Cancer Res. 2017 Feb;15(2):152-164. doi: 10.1158/1541-7786.MCR-16-0283. Epub 2016 Nov 15.
10
Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis.
PPAR Res. 2016;2016:2198645. doi: 10.1155/2016/2198645. Epub 2016 May 12.

本文引用的文献

1
A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer.
Cancer Res. 2006 Nov 15;66(22):10639-42. doi: 10.1158/0008-5472.CAN-06-2522.
2
Negative regulation of hormone signaling by RIP140.
J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):51-9. doi: 10.1016/j.jsbmb.2006.09.005. Epub 2006 Oct 23.
3
Induction of human CYP2A6 is mediated by the pregnane X receptor with peroxisome proliferator-activated receptor-gamma coactivator 1alpha.
J Pharmacol Exp Ther. 2006 Nov;319(2):693-702. doi: 10.1124/jpet.106.107573. Epub 2006 Jul 20.
5
Selective induction of intestinal CYP3A23 by 1alpha,25-dihydroxyvitamin D3 in rats.
Biochem Pharmacol. 2006 Jul 28;72(3):385-92. doi: 10.1016/j.bcp.2006.04.033.
6
Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells.
Endocrinology. 2006 Aug;147(8):3843-50. doi: 10.1210/en.2006-0358. Epub 2006 May 11.
7
Transcriptional regulation of the human pregnane-X receptor.
Drug Metab Rev. 2006;38(1-2):31-49. doi: 10.1080/03602530600569810.
8
Retinoids activate the RXR/SXR-mediated pathway and induce the endogenous CYP3A4 activity in Huh7 human hepatoma cells.
Toxicol Sci. 2006 Jul;92(1):51-60. doi: 10.1093/toxsci/kfj207. Epub 2006 Apr 21.
9
MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers.
Cancer Sci. 2006 May;97(5):374-9. doi: 10.1111/j.1349-7006.2006.00186.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验